Emerging studies suggest Retatrutide , a dual stimulator targeting both GLP-1 and GIP , appears to represent a promising development for weight management . Early patient trials have demonstrated impressive losses in visceral fat , conceivably exceeding other body composition treatments. Nevertheless , additional study is required to completely und